| Filed | Form | Issuer | Stake | Shares | Intent | |
|---|---|---|---|---|---|---|
| 2026-09-09 | SCHEDULE 13D | Odysight.ai Inc.ODYS | 33.34% | 4,135,724 | view → | |
| 2024-07-01 | SC | Eiger BioPharmaceuticals, Inc. | — | — | view → | |
| 2024-04-08 | SC | Sol-Gel Technologies Ltd.SLGL | — | — | view → | |
| 2023-03-20 | SC | Sol-Gel Technologies Ltd.SLGL | — | — | view → | |
| 2020-12-17 | SC | Keros Therapeutics, Inc.KROS | — | — | view → | |
| 2020-11-25 | SC | Keros Therapeutics, Inc.KROS | — | — | view → | |
| 2020-04-20 | SC | Sol-Gel Technologies Ltd.SLGL | — | — | view → | |
| 2019-12-19 | SC | Aclaris Therapeutics, Inc.ACRS | — | — | view → | |
| 2019-11-21 | SC | Aclaris Therapeutics, Inc.ACRS | — | — | view → | |
| 2019-06-03 | SC | UroGen Pharma Ltd.URGN | — | — | view → |
Free. We email you when criteria match. One-click unsubscribe in every email.
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →